FDA
-
-
-
-
-
-
-
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
-
-
-
-
-
-
-
BeOne Medicines receives FDA fast track status for liver cancer drug
-
-
-
-
-
-
-
BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
-
-
-
-
-
-
-
FDA approves BeOne's (ONC) BRUKINSA tablet
-
-
-
-
-
-
-
BeiGene (BGNE) Announces TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy
-
-
-
-
-
-
-
BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
-
-
-
-
-
-
-
Pi Health Raises Over $30M in Series A to Revolutionize Cancer Care and Clinical Trials
-
327,482 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

